Biomerica, Inc. (BMRA)
Largest Insider Buys in Sector
BMRA Stock Price History Chart
BMRA Stock Performance
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Insider Activity of Biomerica, Inc.
Over the last 12 months, insiders at Biomerica, Inc. have bought $0 and sold $0 worth of Biomerica, Inc. stock.
On average, over the past 5 years, insiders at Biomerica, Inc. have bought $45,752 and sold $80,878 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $310 was made by Irani Zackary S. (Chief Executive Officer) on 2023‑05‑25.
List of Insider Buy and Sell Transactions, Biomerica, Inc.
| 2023-05-25 | Chief Executive Officer | 200 0.0015% | $1.55 | $310 | -33.33% | |||
| 2023-05-24 | Chief Executive Officer | 500 0.0037% | $1.61 | $805 | -37.04% | |||
| 2023-05-12 | Chief Executive Officer | 1,700 0.0132% | $1.17 | $1,989 | -7.14% | |||
| 2023-05-10 | Chief Executive Officer | 500 0.0038% | $1.27 | $635 | -16.40% | |||
| 2023-05-09 | Chief Executive Officer | 300 0.0024% | $1.39 | $417 | -18.60% | |||
| 2023-05-04 | Chief Executive Officer | 1,000 0.0073% | $1.36 | $1,360 | -23.19% | |||
| 2023-04-28 | Chief Executive Officer | 1,800 0.0135% | $1.34 | $2,412 | -18.80% | |||
| 2023-04-27 | Chief Executive Officer | 2,600 0.0194% | $1.31 | $3,406 | -16.92% | |||
| 2023-04-26 | Chief Executive Officer | 7,000 0.0528% | $1.26 | $8,820 | -12.90% | |||
| 2023-01-27 | Executive Vice Chairman | 1,538 0.0116% | $2.94 | $4,522 | -55.86% | |||
| 2023-01-26 | director | 2,190 0.016% | $2.96 | $6,482 | -57.33% | |||
| 2023-01-25 | Chief Executive Officer | 1,800 0.013% | $2.85 | $5,130 | -55.82% | |||
| 2023-01-24 | Chief Executive Officer | 2,000 0.0149% | $2.81 | $5,620 | -53.93% | |||
| 2020-10-26 | director | 9,100 0.0773% | $5.45 | $49,595 | -8.79% | |||
| 2020-04-21 | Sale | director | 5,000 0.0429% | $8.11 | $40,532 | -16.09% | ||
| 2020-04-17 | Sale | director | 5,000 0.0419% | $8.07 | $40,346 | -17.46% | ||
| 2018-02-09 | Chief Executive Officer | 500 0.0057% | $3.83 | $1,915 | -7.18% | |||
| 2018-02-02 | Chief Executive Officer | 1,000 0.0119% | $3.96 | $3,960 | -6.68% | |||
| 2018-01-25 | Chief Executive Officer | 2,039 0.0237% | $4.03 | $8,209 | -9.16% | |||
| 2018-01-25 | director | 8,200 0.0992% | $4.18 | $34,276 | -9.16% |
Insider Historical Profitability
| Irani Zackary S. | Chief Executive Officer | 1020560 6.067% | $0.30 | 34 | 0 | <0.0001% |
| MOORE JANET TRUST DTD 8/21/98 | 635977 3.7807% | $0.30 | 1 | 0 | <0.0001% | |
| IRANI ZACKARY | Chief Executive Officer | 271526 1.6142% | $0.30 | 1 | 0 | |
| MOORE JANET | Chief Financial Officer | 140720 0.8365% | $0.30 | 2 | 6 | <0.0001% |
| CANO FRANCIS | director | 133736 0.795% | $0.30 | 7 | 0 | <0.0001% |
| BARBIERI ALLEN | Executive Vice Chairman | 101327 0.6024% | $0.30 | 3 | 0 | <0.0001% |
| CAPITANIO FRANCIS E | President | 87000 0.5172% | $0.30 | 0 | 10 | |
| Coste Catherine | director | 43790 0.2603% | $0.30 | 2 | 0 | <0.0001% |
| Emerson Jane | director | 21000 0.1248% | $0.30 | 1 | 0 | <0.0001% |
| Sirgo Mark A | director | 8700 0.0517% | $0.30 | 3 | 2 | +21.92% |
Institutional Investor Ownership
| Granahan Investment Management | $939,762.00 | 6.72 | 1.13M | +4.33% | +$38,979.19 | 0.03 | |
| Wasatch Advisors | $793,116.00 | 5.67 | 953,264 | 0% | +$0 | <0.01 | |
| The Vanguard Group | $506,992.00 | 3.62 | 609,365 | 0% | +$0 | <0.0001 | |
| Russell Investments Group Ltd | $187,561.00 | 1.34 | 225,435 | +11.84% | +$19,861.41 | <0.0001 | |
| BlackRock | $124,035.00 | 0.89 | 149,081 | -0.42% | -$520.83 | <0.0001 | |
| Geode Capital Management | $105,276.00 | 0.75 | 126,506 | +4.74% | +$4,761.74 | <0.0001 | |
| Susquehanna International Group | $54,449.00 | 0.39 | 65,444 | -13.79% | -$8,712.64 | <0.0001 | |
| Fore Capital Llc | $49,654.00 | 0.36 | 59,680 | +72.09% | +$20,800.10 | 0.31 | |
| Boothbay Fund Management LLC | $43,176.00 | 0.31 | 51,894 | New | +$43,176.00 | <0.01 | |
| State Street | $30,976.00 | 0.22 | 37,231 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $29,441.00 | 0.21 | 35,386 | New | +$29,441.00 | <0.0001 | |
| UBS | $27,498.00 | 0.2 | 33,051 | +550.61% | +$23,271.51 | <0.0001 | |
| Newedge Advisors Llc | $27,206.00 | 0.19 | 32,700 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $23,904.00 | 0.17 | 28,800 | +37.14% | +$6,474.00 | <0.0001 | |
| Elequin Securities Llc | $17,389.00 | 0.12 | 20,900 | New | +$17,389.00 | <0.01 | |
| Penn Capital Management Co Inc | $17,389.00 | 0.12 | 20,900 | 0% | +$0 | <0.01 | |
| Northern Trust | $17,216.00 | 0.12 | 20,692 | -0.64% | -$111.49 | <0.0001 | |
| Hrt Financial Llc | $14,000.00 | 0.1 | 17,269 | New | +$14,000.00 | <0.0001 | |
| Raymond James Financial Services Advisors Inc | $12,064.00 | 0.09 | 14,500 | 0% | +$0 | <0.0001 | |
| TWO SIGMA SECURITIES LLC | $11,121.00 | 0.08 | 13,366 | -8.5% | -$1,032.56 | <0.0001 | |
| Hollencrest Capital Management | $10,675.00 | 0.08 | 12,830 | +55.52% | +$3,810.72 | <0.0001 | |
| Two Sigma | $9,678.00 | 0.07 | 11,632 | New | +$9,678.00 | <0.0001 | |
| Orion Capital Management LLC | $8,736.00 | 0.06 | 10,500 | 0% | +$0 | 0.01 | |
| Johnson Investment Counsel Inc | $8,403.00 | 0.06 | 10,100 | New | +$8,403.00 | <0.0001 | |
| Coyle Financial Counsel | $8,320.00 | 0.06 | 10,000 | New | +$8,320.00 | <0.01 | |
| Wells Fargo | $5,508.00 | 0.04 | 6,620 | +0.03% | +$1.66 | <0.0001 | |
| Tower Research Capital | $3,831.00 | 0.03 | 4,605 | -25.67% | -$1,322.76 | <0.0001 | |
| Cibc Private Wealth Group Llc | $2,217.00 | 0.02 | 2,600 | New | +$2,217.00 | <0.0001 | |
| Morgan Stanley | $483.00 | <0.01 | 580 | -35.2% | -$262.32 | <0.0001 | |
| Huntington National Bank | $250.00 | <0.01 | 300 | New | +$250.00 | <0.0001 | |
| Cornerstone Planning Group Llc | $112.00 | <0.01 | 200 | 0% | +$0 | <0.0001 | |
| Bank of America | $166.00 | <0.01 | 200 | -9.09% | -$16.60 | <0.0001 | |
| Qube Research & Technologies | $42.00 | <0.01 | 50 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $32.00 | <0.01 | 39 | +39.29% | +$9.03 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 57 | 0% | +$0 | <0.0001 | |
| Group One Trading | $56.00 | <0.01 | 67 | New | +$56.00 | <0.0001 |